カテゴリー： 世界, 医療/バイオ, Grand View Research

世界の上流バイオプロセス市場（2023-2030）：製品別、ワークフロー別（培地調製、細胞培養、細胞分離）、使用種類別（マルチユース、シングルユース）、モード別、地域別

【英語タイトル】Upstream Bioprocessing Market Size, Share & Trends Analysis Report By Product, By Workflow (Media Preparation, Cell Culture, Cell Separation), By Use Type (Multi-Use, Single-Use), By Mode, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23NOV169）・商品コード：GRV23NOV169
・発行会社（調査会社）：Grand View Research
・発行日：2023年9月
・ページ数：145
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：バイオテクノロジー
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

上流バイオプロセス市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界の上流バイオプロセス市場規模は、2023年から2030年にかけて年平均成長率16.6%で拡大し、2030年には591億ドルに達する見込みです。バイオ医薬品の商業的成功と幅広い受容は、いくつかの自社製造および受託製造のバイオ医薬品企業に有利な成長の道を提供しています。さらに、バイオシミラーや生物製剤の需要の高さ、費用対効果の高い改良技術の発売、シングルユースシステムの受け入れ拡大などの要因が重なり、市場の収益が伸びています。

新興企業や新規参入企業は、新しいバイオ製造プラントを設立する際に予算の制約に直面することがよくあります。そのため、これらの事業体は、製造プロセスを受託サービスに委託することでバイオ治療薬のポートフォリオを拡大し、上流バイオプロセスサービスの収益拡大に貢献しています。

連続的な上流バイオプロセスは、バイオプロセス産業に大きな利益をもたらしています。バイオリアクター培養の清澄化のために、音響波技術や連続遠心分離のような方法の導入が増加し、清澄化の負担が最小化される傾向にあります。その結果、細胞培養の密度が高まり、効率的な上流工程が実現します。

タンパク質発現とクローン・スクリーニングに関する細胞株生産性の継続的な進歩により、予測期間中、細胞培養製品のCAGRは最も速くなると予想されます。細胞培養は、上流のバイオプロセスにおいて最も困難で重要なステップと考えられているため、技術的な複雑さに関してより多くの注意を払う必要があり、その結果、上流のバイオプロセス市場で最大のシェアを占めています。

マルチユースシステムは、投資が1回で済み、より大量のバイオプロセスに適用可能で、pHと酸素を正確に維持するため、これらのシステムの使用率が高くなっています。しかし、従来のステンレス製バイオリアクターからシングルユースバイオリアクターシステムへのパラダイムシフトが、シングルユース分野の有利な成長の要因となっています。

主要市場プレーヤーは、市場での存在感を強化するために、新規製品開発、互恵的パートナーシップ、協定、地理的拡大などの戦略的イニシアチブを採用しています。例えば、2019年2月、Danaher Corporationは、GE Life SciencesのBiopharma事業を買収する契約を締結しました。この買収により、ダナハーはGEバイオファーマの細胞培養培地、シングルユース技術、開発機器、消耗品を既存のポートフォリオに加え、市場でのプレゼンスを拡大しました。

上流バイオプロセス市場のレポートハイライト

- バイオリアクターの高い可用性と、主要市場企業によるシングルユースバイオリアクターの継続的な発売が、バイオリアクター分野の顕著な収益シェアの要因です。

- 社内でバイオ生産を行うことができる老舗のバイオ医薬品製造企業の存在が、このセグメントの最大収益シェアにつながっています。

- CMOによるシングルユースシステムの工場への統合を通じた投資の増加および製造能力の拡大により、上流バイオプロセスのアウトソーシングモードが予測期間中に最も速いCAGRを記録すると予測されています。

- 北米は、バイオテクノロジーにおける継続的な技術革新とバイオ医薬品に対する嗜好の高まりにより、世界のアップストリーム・バイオプロセシング市場を席巻しています。さらに、社内にバイオ医薬品メーカーが多数存在し、米国の生物製剤市場に多くの投資が行われていることも成長を後押ししています。

- アジア太平洋地域は、上流のワークフローで工程内管理に使用できる迅速な分析手法に対する意識の高まりにより、予測期間中に最も速いCAGRを記録する見込みです。

第1章. 調査方法・範囲
第2章. エグゼクティブサマリー
第3章. 市場変動・動向・範囲
第4章. 世界の上流バイオプロセス市場：製品別予測・動向分析
第5章. 世界の上流バイオプロセス市場：ワークフロー別予測・動向分析
第6章. 世界の上流バイオプロセス市場：使用タイプ別予測・動向分析
第7章. 世界の上流バイオプロセス市場：モード別予測・動向分析
第8章. 世界の上流バイオプロセス市場：地域別予測・動向分析
第9章. 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Workflow
1.1.3. Use Type
1.1.4. Mode
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Workflow outlook
2.2.3. Use type outlook
2.2.4. Mode outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Upstream Bioprocessing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Upstream Bioprocessing Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Upstream Bioprocessing: Product Estimates & Trend Analysis
4.1. Upstream Bioprocessing Market: Key Takeaways
4.2. Upstream Bioprocessing Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Bioreactors/Fermenters
4.3.1. Bioreactors/Fermenters market estimates and forecasts, 2018 to 2030 (USD Billion)
4.4. Cell Culture Products
4.4.1. Cell culture products market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5. Filters
4.5.1. Filters market estimates and forecasts, 2018 to 2030 (USD Billion)
4.6. Bioreactors Accessories
4.6.1. Bioreactors accessories market estimates and forecasts, 2018 to 2030 (USD Billion)
4.7. Bags & Containers
4.7.1. Bags & containers market estimates and forecasts, 2018 to 2030 (USD Billion)
4.8. Others
4.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 5. Upstream Bioprocessing: Workflow Estimates & Trend Analysis
5.1. Upstream Bioprocessing Market: Key Takeaways
5.2. Upstream Bioprocessing Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Media Preparation
5.3.1. Media preparation market estimates and forecasts, 2018 to 2030 (USD Billion)
5.4. Cell Culture
5.4.1. Cell culture market estimates and forecasts, 2018 to 2030 (USD Billion)
5.5. Cell Separation
5.5.1. Cell separation market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 6. Upstream Bioprocessing: Use Type Estimates & Trend Analysis
6.1. Upstream Bioprocessing Market: Key Takeaways
6.2. Upstream Bioprocessing Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Multi-Use
6.3.1. Multi-use market estimates and forecasts, 2018 to 2030 (USD Billion)
6.4. Single-Use
6.4.1. Single-use market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 7. Upstream Bioprocessing: Mode Estimates & Trend Analysis
7.1. Upstream Bioprocessing Market: Key Takeaways
7.2. Upstream Bioprocessing Market: Movement & Market Share Analysis, 2022 & 2030
7.3. In-House
7.3.1. In-house market estimates and forecasts, 2018 to 2030 (USD Billion)
7.4. Outsourced
7.4.1. Outsourced market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 8. Upstream Bioprocessing Market: Regional Estimates & Trend Analysis
8.1. Regional Outlook
8.2. Upstream Bioprocessing Market by Region: Key Takeaways
8.3. North America
8.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.3.2. U.S.
8.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.3.3. Canada
8.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.4. Europe
8.4.1. UK
8.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.4.2. Germany
8.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.4.3. France
8.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.4.4. Italy
8.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.4.5. Spain
8.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.4.6. Sweden
8.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.4.7. Norway
8.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.4.8. Denmark
8.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.5. Asia Pacific
8.5.1. Japan
8.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.5.2. China
8.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.5.3. India
8.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.5.4. Australia
8.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.5.5. Thailand
8.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.5.6. South Korea
8.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.6.2. Mexico
8.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.6.3. Argentina
8.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.7. MEA
8.7.1. South Africa
8.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.7.2. Saudi Arabia
8.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.7.3. UAE
8.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.7.4. Kuwait
8.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Market Participant Categorization
9.2.1. GE HealthCare
9.2.1.1. Company overview
9.2.1.2. Financial performance
9.2.1.3. Product benchmarking
9.2.1.4. Strategic initiatives
9.2.2. Thermo Fisher Scientific Inc.
9.2.2.1. Company overview
9.2.2.2. Financial performance
9.2.2.3. Product benchmarking
9.2.2.4. Strategic initiatives
9.2.3. Merck KGaA
9.2.3.1. Company overview
9.2.3.2. Financial performance
9.2.3.3. Product benchmarking
9.2.3.4. Strategic initiatives
9.2.4. Corning, Inc.
9.2.4.1. Company overview
9.2.4.2. Financial performance
9.2.4.3. Product benchmarking
9.2.4.4. Strategic initiatives
9.2.5. Sartorius AG
9.2.5.1. Company overview
9.2.5.2. Financial performance
9.2.5.3. Product benchmarking
9.2.5.4. Strategic initiatives
9.2.6. Eppendorf AG
9.2.6.1. Company overview
9.2.6.2. Financial performance
9.2.6.3. Product benchmarking
9.2.6.4. Strategic initiatives
9.2.7. Danaher
9.2.7.1. Company overview
9.2.7.2. Financial performance
9.2.7.3. Product benchmarking
9.2.7.4. Strategic initiatives
9.2.8. Boehringer Ingelheim GmbH
9.2.8.1. Company overview
9.2.8.2. Financial performance
9.2.8.3. Product benchmarking
9.2.8.4. Strategic initiatives
9.2.9. Applikon Biotechnology
9.2.9.1. Company overview
9.2.9.2. Financial performance
9.2.9.3. Product benchmarking
9.2.9.4. Strategic initiatives
9.2.10. PBS Biotech, Inc.
9.2.10.1. Company overview
9.2.10.2. Financial performance
9.2.10.3. Product benchmarking
9.2.10.4. Strategic initiatives
9.2.11. Lonza
9.2.11.1. Company overview
9.2.11.2. Financial performance
9.2.11.3. Product benchmarking
9.2.11.4. Strategic initiatives
9.2.12. CellGenix GmbH
9.2.12.1. Company overview
9.2.12.2. Financial performance
9.2.12.3. Product benchmarking
9.2.12.4. Strategic initiatives
9.2.13. Samsung BioLogics
9.2.13.1. Company overview
9.2.13.2. Financial performance
9.2.13.3. Product benchmarking
9.2.13.4. Strategic initiatives
9.2.14. AGC Inc.
9.2.14.1. Company overview
9.2.14.2. Financial performance
9.2.14.3. Product benchmarking
9.2.14.4. Strategic initiatives
9.2.15. VWR International, LLC
9.2.15.1. Company overview
9.2.15.2. Financial performance
9.2.15.3. Product benchmarking
9.2.15.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviations
Table 2 North America upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 3 North America upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 4 North America upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 5 North America upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 6 North America upstream bioprocessing market, by region 2018 - 2030 (USD Billion)
Table 7 U.S. upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 8 U.S. upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 9 U.S. upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 10 U.S. upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 11 Canada upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 12 Canada upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 13 Canada upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 14 Canada upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 15 Europe upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 16 Europe upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 17 Europe upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 18 Europe upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 19 Europe upstream bioprocessing market, by region 2018 - 2030 (USD Billion)
Table 20 Germany upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 21 Germany upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 22 Germany upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 23 Germany upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 24 UK upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 25 UK upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 26 UK upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 27 UK upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 28 France upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 29 France upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 30 France upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 31 France upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 32 Italy upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 33 Italy upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 34 Italy upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 35 Italy upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 36 Spain upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 37 Spain upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 38 Spain upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 39 Spain upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 40 Sweden upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 41 Sweden upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 42 Sweden upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 43 Sweden upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 44 Norway upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 45 Norway upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 46 Norway upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 47 Norway upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 48 Denmark upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 49 Denmark upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 50 Denmark upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 51 Denmark upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 52 Asia Pacific upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 53 Asia Pacific upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 54 Asia Pacific upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 55 Asia Pacific upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 56 Asia Pacific upstream bioprocessing market, by region 2018 - 2030 (USD Billion)
Table 57 Japan upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 58 Japan upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 59 Japan upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 60 Japan upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 61 China upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 62 China upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 63 China upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 64 China upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 65 India upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 66 India upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 67 India upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 68 India upstream bioprocessing market, by mode (USD Billion) 2018 - 2030
Table 69 Australia upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 70 Australia upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 71 Australia upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 72 Australia upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 73 Thailand upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 74 Thailand upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 75 Thailand upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 76 Thailand upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 77 South Korea upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 78 South Korea upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 79 South Korea upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 80 South Korea upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 81 Latin America upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 82 Latin America upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 83 Latin America upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 84 Latin America upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 85 Latin America upstream bioprocessing market, by region 2018 - 2030 (USD Billion)
Table 86 Brazil upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 87 Brazil upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 88 Brazil upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 89 Brazil upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 90 Mexico upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 91 Mexico upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 92 Mexico upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 93 Mexico upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 94 Argentina upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 95 Argentina upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 96 Argentina upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 97 Argentina upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 98 Middle East and Africa upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 99 Middle East and Africa upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 100 Middle East and Africa upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 101 Middle East and Africa upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 102 Middle East and Africa upstream bioprocessing market, by region 2018 - 2030 (USD Billion)
Table 103 South Africa upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 104 South Africa upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 105 South Africa upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 106 South Africa upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 107 Saudi Arabia upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 108 Saudi Arabia upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 109 Saudi Arabia upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 110 Saudi Arabia upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 111 UAE upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 112 UAE upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 113 UAE upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 114 UAE upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 115 Kuwait upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 116 Kuwait upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 117 Kuwait upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 118 Kuwait upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Upstream bioprocessing: Market outlook
Fig. 8 Upstream bioprocessing: Competitive insights
Fig. 9 Parent market outlook
Fig. 10 Related/ancillary market outlook
Fig. 11 Penetration and growth prospect mapping
Fig. 12 Industry value chain analysis
Fig. 13 Upstream bioprocessing market driver impact
Fig. 14 Upstream bioprocessing market restraint impact
Fig. 15 Upstream bioprocessing market strategic initiatives analysis
Fig. 16 Upstream bioprocessing market: Product movement analysis
Fig. 17 Upstream bioprocessing market: Product outlook and key takeaways
Fig. 18 Bioreactors/Fermenters market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 19 Cell culture products market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 20 Filters market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 21 Bioreactors accessories market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 22 Bags & containers market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 23 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 24 Upstream bioprocessing market: Workflow movement analysis
Fig. 25 Upstream bioprocessing market: Workflow outlook and key takeaways
Fig. 26 Media preparation market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 27 Cell culture market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 28 Cell separation market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 29 Upstream bioprocessing market: Use type movement analysis (USD Billion)
Fig. 30 Upstream bioprocessing market: Use type outlook and key takeaways
Fig. 31 Multi-use market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 32 Single-use market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 33 Upstream bioprocessing market: Mode movement analysis
Fig. 34 Upstream bioprocessing market: Mode outlook and key takeaways
Fig. 35 In-house market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 36 Outsourced market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 37 Global upstream bioprocessing market: Regional movement analysis
Fig. 38 Global upstream bioprocessing market: Regional outlook and key takeaways
Fig. 39 North America market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 40 U.S. market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 41 Canada market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 42 Europe market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 43 UK market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 44 Germany market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 45 France market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 46 Italy market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 47 Spain market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 48 Sweden market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 49 Norway market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 50 Denmark market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 51 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 52 Japan market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 53 China market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 54 India market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 55 Australia market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 56 Thailand market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 57 South Korea market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 58 Latin America market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 59 Brazil market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 60 Mexico market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 61 Argentina market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 62 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 63 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 64 South Africa market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 65 UAE market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 66 Kuwait market estimates and forecasts, 2018 - 2030 (USD Billion)

★調査レポート[世界の上流バイオプロセス市場（2023-2030）：製品別、ワークフロー別（培地調製、細胞培養、細胞分離）、使用種類別（マルチユース、シングルユース）、モード別、地域別] (コード：GRV23NOV169)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の上流バイオプロセス市場（2023-2030）：製品別、ワークフロー別（培地調製、細胞培養、細胞分離）、使用種類別（マルチユース、シングルユース）、モード別、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の細胞＆遺伝子治療製造市場2023-2030：治療タイプ別、規模別（R&D）、モード別、ワークフロー別（ベクター生産、セルバンキング）、地域別
  • 世界のシングルユースバイオプロセシング用プローブ＆センサー市場（2023-2030）：ワークフロー別（下流、上流）、センサー種類別、最終用途別、地域別
  • 世界の試験所技能試験市場（2023-2030）：産業別（臨床診断、大麻）、技術別（細胞培養、PCR）、エンドユーザー別（CRO、病院）、地域別
  • 世界のシングルセルゲノムシーケンス市場（2023-2030）：製品種類別（装置、試薬）、疾患領域別（がん、免疫）、技術別、ワークフロー別、用途別、エンドユーザー別、地域別
  • 世界のインフルエンザ診断市場2024-2030：検査タイプ別（RIDT、RT-PCR、細胞培養）、エンドユーザー別（病院、研究所、POCT）、地域別
  • 世界のADME毒性試験市場2023-2030：技術別（細胞培養、オミックス（OMICS）技術）、用途別（神経毒性、腎毒性）、方法別（細胞アッセイ、インシリカ）
  • 世界の滅菌チューブ溶接機市場2023-2030：用途別（バイオ医薬品、血液処理、診断ラボ、その他）、モード別（手動、自動）、最終用途別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆